相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance
Aynaz Mihanfar et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer
Nuray Erin et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Truncation of neurokinin-1 receptorNegative regulation of substance P signaling
Sergei Spitsin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
CD200fc enhances anti-tumoral immune response and inhibits visceral metastasis of breast carcinoma
Nuray Erin et al.
Oncotarget (2018)
Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P
Esra Nizam et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Pathogenesis of Breast Cancer Metastasis to Brain: a Comprehensive Approach to the Signaling Network
Bahrami Tayyeb et al.
MOLECULAR NEUROBIOLOGY (2016)
Activation of neuroimmune pathways increases therapeutic effects of radiotherapy on poorly differentiated breast carcinoma
Nuray Erin et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
The substance PINK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs
Miguel Munoz et al.
JOURNAL OF BIOSCIENCES (2015)
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Douglas Marvel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells
Sarah Mombelli et al.
SCIENTIFIC REPORTS (2015)
The correlations between IL-17 vs. Th17 cells and cancer patient survival: a systematic review
Simone Punt et al.
ONCOIMMUNOLOGY (2015)
Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response
N. Erin et al.
ONCOGENE (2015)
Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma
Nuray Erin et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer
Yunli Zhou et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Interleukin-17: A Promoter in Colorectal Cancer Progression
Dang Wu et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Cytokine patterns in patients with cancer: a systematic review
Bodo E. Lippitz
LANCET ONCOLOGY (2013)
Role of neurokinin-1 receptor in the initiation and maintenance of skin chronic inflammatory diseases
Sherrie J. Divito et al.
IMMUNOLOGIC RESEARCH (2011)
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor
Linda Monaco-Shawver et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists
M. Munoz et al.
CURRENT MEDICINAL CHEMISTRY (2010)
TNFalpha Up-Regulates SLUG Via the NF-kappaB/HIF1alpha Axis, Which Imparts Breast Cancer Cells With a Stem Cell-Like Phenotype
Gianluca Storci et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Francesco Colotta et al.
CARCINOGENESIS (2009)
An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
Dimitrios Iliopoulos et al.
CELL (2009)
Altered gene expression in breast cancer liver metastases
Nuray Erin et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
The NK-1 Receptor Is Expressed in Human Primary Gastric and Colon Adenocarcinomas and Is Involved in the Antitumor Action of L-733,060 and the Mitogenic Action of Substance P on Human Gastrointestinal Cancer Cell Lines
Marisa Rosso et al.
TUMOR BIOLOGY (2008)
NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2
Miguel Munoz et al.
INVESTIGATIONAL NEW DRUGS (2008)
Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation
J. -P. Lai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231
M Bigioni et al.
ANTI-CANCER DRUGS (2005)
The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines
M Muñoz et al.
NEUROPEPTIDES (2005)
Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease
P Sinha et al.
JOURNAL OF IMMUNOLOGY (2005)
Aprepitant in antiemetic combinations to prevent chemotherapy-induced nausea and vomiting
IN Olver
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2004)
Antitumoral action of the neurokinin-1 receptor antagonist L-733060 on human melanoma cell lines
M Muñoz et al.
MELANOMA RESEARCH (2004)
Natural killer cell functions mediated by the neuropeptide substance P
C Feistritzer et al.
REGULATORY PEPTIDES (2003)
Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain
L Caberlotto et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Increased expression of preprotachykinin-1 and neurokinin receptors in human breast cancer cells:: Implications for bone marrow metastasis
D Singh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
